“Adalimumab Combination Therapy Superior for Hidradenitis Suppurativa Treatment”

https://pubmed.ncbi.nlm.nih.gov/38112226

Adalimumab combined with clindamycin and rifampicin shows superior clinical effectiveness in treating hidradenitis suppurativa compared to adalimumab monotherapy, particularly in reducing draining tunnels.